These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 39104525)
1. Understanding tissue-resident macrophages unlocks the potential for novel combinatorial strategies in breast cancer. Biswas M Front Immunol; 2024; 15():1375528. PubMed ID: 39104525 [TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer. Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338 [TBL] [Abstract][Full Text] [Related]
3. The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages. Sami E; Paul BT; Koziol JA; ElShamy WM Cancer Res; 2020 Mar; 80(5):1102-1117. PubMed ID: 31911557 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer cells promote CD169 Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052 [TBL] [Abstract][Full Text] [Related]
5. The obese inflammatory microenvironment may promote breast DCIS progression. Habanjar O; Nehme R; Goncalves-Mendes N; Cueff G; Blavignac C; Aoun J; Decombat C; Auxenfans C; Diab-Assaf M; Caldefie-Chézet F; Delort L Front Immunol; 2024; 15():1384354. PubMed ID: 39072314 [TBL] [Abstract][Full Text] [Related]
6. Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer. Padzińska-Pruszyńska I; Kucharzewska P; Matejuk A; Górczak M; Kubiak M; Taciak B; Król M Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409110 [TBL] [Abstract][Full Text] [Related]
7. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment. Jesser EA; Brady NJ; Huggins DN; Witschen PM; O'Connor CH; Schwertfeger KL Breast Cancer Res; 2021 Nov; 23(1):104. PubMed ID: 34743736 [TBL] [Abstract][Full Text] [Related]
8. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways. Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082 [TBL] [Abstract][Full Text] [Related]
9. The roles of tissue resident macrophages in health and cancer. Cao M; Wang Z; Lan W; Xiang B; Liao W; Zhou J; Liu X; Wang Y; Zhang S; Lu S; Lang J; Zhao Y Exp Hematol Oncol; 2024 Jan; 13(1):3. PubMed ID: 38229178 [TBL] [Abstract][Full Text] [Related]
10. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232 [TBL] [Abstract][Full Text] [Related]
11. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages. Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555 [TBL] [Abstract][Full Text] [Related]
12. Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer. Mehta AK; Kadel S; Townsend MG; Oliwa M; Guerriero JL Front Immunol; 2021; 12():643771. PubMed ID: 33968034 [TBL] [Abstract][Full Text] [Related]
13. TIME Is a Great Healer-Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes. Singh S; Zhang XHF; Rosen JM Cells; 2020 Dec; 10(1):. PubMed ID: 33374595 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer. Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577 [TBL] [Abstract][Full Text] [Related]
15. CD163 Omilian AR; Cannioto R; Mendicino L; Stein L; Bshara W; Qin B; Bandera EV; Zeinomar N; Abrams SI; Hong CC; Yao S; Khoury T; Ambrosone CB Breast Cancer Res; 2024 May; 26(1):75. PubMed ID: 38720366 [TBL] [Abstract][Full Text] [Related]
16. The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer. Zhao Z; Ma X; Cai Z PeerJ; 2024; 12():e17667. PubMed ID: 39006029 [TBL] [Abstract][Full Text] [Related]
17. Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer. Brady NJ; Chuntova P; Schwertfeger KL Mediators Inflamm; 2016; 2016():4549676. PubMed ID: 26884646 [TBL] [Abstract][Full Text] [Related]
18. Tissue-resident macrophages promote extracellular matrix homeostasis in the mammary gland stroma of nulliparous mice. Wang Y; Chaffee TS; LaRue RS; Huggins DN; Witschen PM; Ibrahim AM; Nelson AC; Machado HL; Schwertfeger KL Elife; 2020 Jun; 9():. PubMed ID: 32479261 [TBL] [Abstract][Full Text] [Related]
19. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer. Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567 [TBL] [Abstract][Full Text] [Related]
20. Tissue-resident macrophages - early passengers or drivers in the tumor niche? Vogel A; Weichhart T Curr Opin Biotechnol; 2023 Oct; 83():102984. PubMed ID: 37572419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]